MGH Cardiovascular Research Center (@mghcvrc) header
MGH Cardiovascular Research Center (@mghcvrc) profile picture

Updates and news from the CVRC at Massachusetts General Hospital

Boston, Massachusetts
Joined October 2021
Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)Photo by MGH Cardiovascular Research Center (@mghcvrc)
The Cardiovascular Research Center at MGH, one of the longest established centers dedicated to CV research, is home to over 24 groups of Investigators pursuing basic and translational investigation with the goal of improving cardiovascular treatment and health outcomes.
4
7
2
96
MGH Cardiovascular Research Center retweeted
Presented our cardiovesicle work at #AAEV2026: cardiomyocyte-derived EVs in blood track the heart's response to ischemic stress during cardiopulmonary bypass. A serial window into the myocardium, from a blood draw. Thanks @SaumyaDas_Lab @mghcvrc @MGBResearchNews @AAEV_org @Pri – at Jersey City, NJ
Dr Michail Spanos from Harvard Medical School presented “Circulating cardiomyocyte-derived extracellular vesicle (“cardiovesicles”) capture dynamic myocardial transcriptional responses to ischemic stress during cardiopulmonary bypass”! #aaev2026
2
5
202
MGH Cardiovascular Research Center retweeted
Honoring Ken Bloch’s enduring values, legacy of mentorship, and advocacy for science at the Bloch Memorial Lecture presented by @SaumyaDas_Lab at #AHA26 today. A fitting tribute to a great scientist, mentor and friend. #3CPR
1
5
22
898
MGH Cardiovascular Research Center retweeted
Congratulations to the 2026 Distinguished Scientist Award recipients, recognized for their extraordinary contributions to advancing cardiovascular, stroke, brain and kidney health research. • Zoltan P. Arany, MD, PhD, FAHA • Benoit G. Bruneau, PhD, FAHA • Joseph A. Hill, MD, PhD, FAHA • Richard N. Kitsis, MD, FAHA • Michael A. Moskowitz, MD, FAHA • Katherine R. Tuttle, MD Join us in celebrating this distinguished group of scientists and their lasting impact on discovery, innovation and patient care. #ScientificSessions26
9
3
46
4,956
MGH Cardiovascular Research Center retweeted
Replying to @emilyswlau
@emilyswlau discusses late breaking science from Lp(a) HORIZON at #ScientificSessions26. 🎥
1
10
1
48
2,389
MGH Cardiovascular Research Center retweeted
Great to bring the Ho and Lau Labs together for lunch at #AHA26! ❤️ Celebrating great science, wonderful colleagues, and the next generation of 🫀 researchers. Grateful for this incredible group and all the friendships that make science fun! 🌟
3
3
1
36
1,940
MGH Cardiovascular Research Center retweeted
It’s not all prevention at #AHA26 Here with interventional fellowship classmate @nmbutala and the GOAT of interventional cardiology @krosenfieldMD
3
18
717
MGH Cardiovascular Research Center retweeted
Excited to share the results of our clinical trial #IRONMET-HFpEF. IV ferric derisomaltose vs placebo in HFpEF with iron deficiency showing a 1.1 ml/kg/min improvement in peak VO2 and improved 6MWT & NYHA. @GLewisCardiol @CircAHA @MGBResearchNews @mghcvrc
2
4
15
684
MGH Cardiovascular Research Center retweeted
Proud mentor moment at #AHA26! ❤️ Congratulations to @amandajowell and Sanjana Adurty on their moderated posters on pregnancy CV risk prediction and statin use during pregnancy! Exciting science from the Lau Women's Heart Health Lab. So proud of these rising stars! 🌟
2
6
54
1,421
MGH Cardiovascular Research Center retweeted
🚀 Excited to announce the launch of our lab website! omicsintelligencelab.com/ The Omics Intelligence for Health Lab works across human genetics, multi-omics, clinical informatics, and artificial intelligence with the aim of making personalized medicine the new standard of care. Our work spans the Massachusetts General Hospital Cardiovascular Research Center, the Mass General Brigham Heart and Vascular Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard, an ecosystem that connects discovery science directly to patient care. Please look around our new site to see what we're working on. We are currently looking for passionate researchers to join our team and are always open to exciting collaborations with academia and industry partners. 🔬 For Biotech & Pharma: If you want to run omics-powered mechanistic clinical trials to uncover drug mechanisms, identify biomarker-defined responders, and de-risk your pipeline, our team can help bridge deep multi-omics with clinical trial execution in MGB healthcare setting. 💻 For AI Tech: If you have developed medical AI products and need prospective, rigorous clinical validation within an active hospital system, we are setting up to evaluate and validate your models in real clinical workflows. Please reach out! @MGBResearchNews @mghcvrc @MassGenBrigham @broadinstitute
3
8
24
1,323
MGH Cardiovascular Research Center retweeted
Our new study in @NatureComms led by @MinSeoKim_MD and Yang Sui addresses an important barrier to the clinical implementation of polygenic risk scores (PRS): discordance between published scores and limited transferability across populations. We focused on three diseases where the clinical utility of PRS is increasingly being evaluated: coronary artery disease, breast cancer, and prostate cancer. Despite substantial progress in PRS development, different published scores for the same disease often identify different individuals as high risk. In our analysis, only ~10% of individuals classified as high risk by at least one of five leading CAD PRS were consistently identified by all five. This creates a practical challenge for clinical implementation: Which PRS should a healthcare system use, and how can we ensure that it performs well in its patient population? Rather than developing another PRS, we tested a framework that integrates multiple published scores and uses machine learning to optimize their relative weights based on local patient data. Key findings: 🔷 Local optimization improved predictive discrimination across all three diseases in both the Mass General Brigham Biobank and UK Biobank. 🔷 For CAD, the locally optimized PRS identified a high-risk group with 27.7% disease prevalence, compared with 17.8% using the best-performing published PRS. 🔷 Similar improvements were observed for breast cancer (20.8% vs. 7.1%) and prostate cancer (16.4% vs. 8.8%). 🔷The framework requires no new GWAS, additional genetic testing, or complex upstream model development. ♦️ The broader implication is that PRS should not necessarily be treated as static models developed in one population and applied universally. Local optimization offers a scalable approach to improving prediction, addressing discordance across existing scores, and facilitating implementation across healthcare systems. @AniruddhPatelMD @skoyamamd @kparuchuri @buutrg @injeong_shim @somijemmacho @patrick_ellinor @pnatarajanmd @broadinstitute @MGBResearchNews @mghcvrc Paper: nature.com/articles/s41467-0…
3
13
32
1,744
MGH Cardiovascular Research Center retweeted
Replying to @EricTopol
@EricTopol at #AHA26 on Missed Opportunities in Cardiovascular Medicine Long list starting with 🔸polygenic risk scores 🔸 Highlighting our work at @MGBResearchNews @broadinstitute @mghcvrc over the years @pnatarajanmd @skathire @amitvkhera @AniruddhPatelMD @patrick_ellinor
1
3
26
986
MGH Cardiovascular Research Center retweeted
Celebrating the achievements of our and @mchonig ‘s teams at #AHA26 ! @MGBResearchNews @mghcvrc @broadinstitute
1
11
43
1,929
MGH Cardiovascular Research Center retweeted
So proud of my co-fellow, colleague and friend @emilyswlau winner of #AHA26 Nanette K. Wagner Research Goes Red Award!!
6
2
57
2,932
MGH Cardiovascular Research Center retweeted
Combined rare and common variant prediction in severe hypercholesterolemia Presented by @injeong_shim as #AHA26 award finalist for the Quest Diagnostics Early Investigator Award for Preventive Cardiovascular Research @MGBResearchNews @broadinstitute @pnatarajanmd @patrick_ellinor
4
1
12
1,788
MGH Cardiovascular Research Center retweeted
Delighted to host @josephahill this week for our Inaugural Mass General Brigham Heart & Vascular Institute Research Seminar. Thanks for a provocative forward-looking seminar about the future of cardiometabolic disease—a fitting launch for our series from a giant in CV Medicine!
1
5
24
1,172
MGH Cardiovascular Research Center retweeted
Proud to see Devesh Malik @YaleMed student and @SarnoffCardio Fellow in our lab, present his work at @escardio #ESC2026 Over the past year, Dev has helped us push forward our work on the biological heterogeneity of obesity, and how it may ultimately inform precision prevention. Our new preprint led by Dev and @MinSeoKim_MD shows that genetically defined obesity endotypes respond differently to healthy lifestyle behaviors, suggesting that the benefits of physical activity, diet, sleep, and sedentary behavior may depend in part on the biological pathway driving obesity risk. A step toward moving from “one-size-fits-all” lifestyle advice to precision prevention. 📄 New preprint: doi.org/10.64898/2026.08.25.… @broadinstitute @mghcvrc @MGHHeartHealth @harvardmed
1
2
20
1,118
MGH Cardiovascular Research Center retweeted
New from our group in collaboration with @wallacemwang and team, published today in @NatureCVR Can targeting Lp(a) and LDL-C together provide greater protection from coronary artery disease than targeting either alone? Using human genetics in >470,000 participants across, we found strong evidence that the benefits are additive: → Loss-of-function variants in LPA or PCSK9 were associated with lower CAD risk, and carrying variants in both with even lower risk. → Genetically lower Lp(a) + LDL-C was associated with substantially lower CAD risk than lowering either alone → Even among statin users, genetically lower Lp(a) remained associated with progressively lower CAD risk. → When genetic effects were calibrated to approximate potent Lp(a)- and LDL-C-lowering therapies, combined targeting was associated with ~51% lower CAD risk. → PheWAS across ~2000 phenotypes identified no major adverse safety signal from lifelong dual lowering. As potent Lp(a)-lowering therapies approach clinical practice, these findings support a future where Lp(a) lowering complements aggressive LDL-C lowering to address residual CAD risk. Manuscript link: rdcu.be/jfZAZmU5bRta @MinSeoKim_MD @mchonig @tigerstatdoc @pnatarajanmd @broadinstitute @MGHHeartHealth @mghcvrc @harvardmed
4
12
40
2,303
MGH Cardiovascular Research Center retweeted
I’m truly honored by this recognition from @American_Heart. And in my new career phase, I’m excited to translate compelling population-level human biological insights into important medicines for patients. @Amgen @MGBResearchNews @CGM_MGH @mghcvrc @harvardmed @broadinstitute @AHAScience @HeartNews
24
15
5
212
18,748
MGH Cardiovascular Research Center retweeted
Some personal news!🔥 I'm joining the faculty at Mass General Hospital Cardiovascular Research Center and Mass General Brigham Heart and Vascular Institute, with incoming appointments as Assistant Professor at Harvard Medical School and Associate Member at the Broad Institute of MIT and Harvard. I'll be launching my research group (Omics Intelligence for Health Lab) within this remarkable scientific ecosystem spanning MGH, MGB HVI, HMS, and Broad Institute, with the goal of establishing personalized medicine as the new standard of care. I couldn't have asked for better mentors than @patrick_ellinor and @aklfahed, who brought me to this point. My goal now is to become the kind of mentor they are, and to pay it forward. We have some open positions. More details on research area: lnkd.in/p/dPsZtEjD @MassGenBrigham @mghcvrc @broadinstitute @harvardmed @MGBResearchNews @MGHMedicine
8
6
1
65
6,733
MGH Cardiovascular Research Center retweeted
In our second paper in @JACCJournals this year, we explore the association between age-related loss of chromosome Y, atrial fibrillation, and mortality. Our findings highlight the role of genomic aging in AF risk. Grateful to our team and collaborators! jacc.org/doi/10.1016/j.jacep…
2
7
247